Acorn Financial Advisory Services Inc Amgen Inc Transaction History

Acorn Financial Advisory Services Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $4,602 - $5,192	-18 Reduced 2.3%	764 $220,000
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $170,984 - $212,281	782 New	782 $210,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $223,095 - $261,383	-1,051 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$233.58 - $259.14 $15,883 - $17,621	68 Added 6.92%	1,051 $256,000
Q3 2020 Oct 15, 2020	BUY	$234.65 - $260.95 $469 - $521	2 Added 0.2%	983 $250,000
Q2 2020 Jul 10, 2020	SELL	$197.81 - $242.74 $23,341 - $28,643	-118 Reduced 10.74%	981 $231,000
Q1 2020 Apr 15, 2020	SELL	$182.24 - $241.7 $3,827 - $5,075	-21 Reduced 1.88%	1,099 $222,000
Q4 2019 Jan 27, 2020	BUY	$189.21 - $243.2 $211,915 - $272,384	1,120 New	1,120 $269,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Acorn Financial Advisory Services Inc , based on Form 13F filings with the SEC.

Stay updated on Acorn Financial Advisory Services Inc with notifications on news.